These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37858631)

  • 81. The Roles of Inflammation in Keloid and Hypertrophic Scars.
    Wang ZC; Zhao WY; Cao Y; Liu YQ; Sun Q; Shi P; Cai JQ; Shen XZ; Tan WQ
    Front Immunol; 2020; 11():603187. PubMed ID: 33343575
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Centella asiatica (Centellicum®) facilitates the regular healing of surgical scars in subjects at high risk of keloids.
    Cotellese R; Hu S; Belcaro G; Ledda A; Feragalli B; Dugall M; Hosoi M; Ippolito E
    Minerva Chir; 2018 Apr; 73(2):151-156. PubMed ID: 29623705
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Fibroproliferative scars.
    Rahban SR; Garner WL
    Clin Plast Surg; 2003 Jan; 30(1):77-89. PubMed ID: 12636218
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction.
    Ogawa R; Akaishi S; Huang C; Dohi T; Aoki M; Omori Y; Koike S; Kobe K; Akimoto M; Hyakusoku H
    J Nippon Med Sch; 2011; 78(2):68-76. PubMed ID: 21551963
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ?
    Adv Skin Wound Care; 2018 Jan; 31(1):E1. PubMed ID: 29240593
    [No Abstract]   [Full Text] [Related]  

  • 86. [Hyperplastic scars and keloids: part II: Surgical and non-surgical treatment modalities].
    Baisch A; Riedel F
    HNO; 2006 Dec; 54(12):981-92; quiz 993-4. PubMed ID: 17033787
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Scars.
    Elsaie ML; Choudhary S; McLeod M; Nouri K
    Curr Probl Dermatol; 2011; 42():131-139. PubMed ID: 21865805
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Targeting Diverse Wounds and Scars: Recent Innovative Bio-design of Microneedle Patch for Comprehensive Management.
    Zhuang ZM; Wang Y; Feng ZX; Lin XY; Wang ZC; Zhong XC; Guo K; Zhong YF; Fang QQ; Wu XJ; Chen J; Tan WQ
    Small; 2024 May; 20(18):e2306565. PubMed ID: 38037685
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hypertrophic scars and keloids in surgery: current concepts.
    Song C
    Ann Plast Surg; 2014 Sep; 73 Suppl 1():S108-18. PubMed ID: 25115371
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.
    Slemp AE; Kirschner RE
    Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Reducing Risks of Facial Scarring.
    Hom DB; Bernstein JD
    Facial Plast Surg Clin North Am; 2023 May; 31(2):195-207. PubMed ID: 37001923
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Detection of apoptosis by in situ labeling and study on the expression of PCNA in hypertrophic scars and keloids].
    Zhao BC; Qian L
    Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):73-6. PubMed ID: 12212258
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Keloids and Hypertrophic Scars.
    Knowles A; Glass DA
    Dermatol Clin; 2023 Jul; 41(3):509-517. PubMed ID: 37236718
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Krox20 expression in abnormal scars: An immunohistochemical study.
    Bakry OA; Samaka RM; Fayez N; Seleit I
    J Cosmet Dermatol; 2022 Oct; 21(10):5116-5126. PubMed ID: 35416391
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study.
    Saray Y; Güleç AT
    Int J Dermatol; 2005 Sep; 44(9):777-84. PubMed ID: 16135153
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Latest Strategy for Keloid and Hypertrophic Scar Prevention and Treatment: The Nippon Medical School (NMS) Protocol.
    Ogawa R; Dohi T; Tosa M; Aoki M; Akaishi S
    J Nippon Med Sch; 2021 Mar; 88(1):2-9. PubMed ID: 32741903
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Recurrence rates in the treatment of keloids and hypertrophic scars with intralesional triamcinolone combined with other intralesional agents.
    Rimmer SN; Chandy RJ; Khan D; Feldman SR
    Arch Dermatol Res; 2023 Dec; 315(10):2757-2767. PubMed ID: 37432467
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Keloids and hypertrophic scars.
    English RS; Shenefelt PD
    Dermatol Surg; 1999 Aug; 25(8):631-8. PubMed ID: 10491047
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Role of Physical Therapies in Wound Healing and Assisted Scarring.
    Fernández-Guarino M; Bacci S; Pérez González LA; Bermejo-Martínez M; Cecilia-Matilla A; Hernández-Bule ML
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108650
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Laser treatment of keloids and hypertrophic scars.
    Bouzari N; Davis SC; Nouri K
    Int J Dermatol; 2007 Jan; 46(1):80-8. PubMed ID: 17214728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.